NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Wednesday that it successfully completed the previously announced repurchase of convertible notes due in 2026 and the issuance of new convertible notes due in 2019 and 2021.

The transactions are anticipated to raise $300 million in net proceeds, to be used for general corporate purposes, Qiagen said.